Circuit Training and Retina
Cognitive Impairment, Progressive, Cerebral Small Vessel Diseases
About this trial
This is an interventional treatment trial for Cognitive Impairment, Progressive focused on measuring Circuit Resistance Training, High-velocity Training, Retinal Microvasculature, Cognitive Function
Eligibility Criteria
Inclusion Criteria: 65-90 years of age; Montreal Cognitive Assessment (MoCA) > 23 no memory loss complaints Exclusion Criteria: Uncontrolled cardiovascular or neuromuscular diseases that prevent participation in a training program; Cerebrovascular disease; Malignancy within the previous 5 years; Documented HIV infection or other immunodeficiency syndrome; Any systemic inflammatory or autoimmune conditions such as rheumatoid arthritis, systemic lupus erythematosus, or other serious concomitant medical illness; A history of ocular surgeries (except for cataract surgery more than 6 months ago) or other ocular diseases; Bilateral moderate or severe cataracts; Refractive errors of myopia, hyperopia and/or astigmatism more than 6.0 Diopters.
Sites / Locations
- Laboratory of Neuromuscular Research and Active Aging
- Laboratory of Neuromuscular Research and Active Aging
Arms of the Study
Arm 1
Arm 2
Experimental
Other
High-Speed Circuit Resistance Training Group
Control Group
Participants in this group will receive high-speed circuit resistance training 3 times a week for 24 consecutive weeks for a total of 72 training sessions.
Participants in this arm will receive two lectures on fitness, diet, or cognition each month for 24 weeks for a total of 12 lectures.